Company:  AYTU BIOPHARMA, INC (AYTU)
Form Type:  S-8
Filing Date:  7/2/2015 
CIK:  0001385818 
Address:  373 INVERNESS PARKWAY
SUITE 206
 
City, State, Zip:  ENGLEWOOD, Colorado 80112 
Telephone:  (720) 437-6580 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$0.29  
Change: 
-0.002 (-0.62%)  
Trade Time: 
Aug 12  
Market Cap: 
$17.54M
Trade AYTU now with

© 2022  
Description of Business
We are a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address needs in both prescription and consumer health categories. Through our prescription business, and following our recent merger with Neos Therapeutics, Inc. ("Neos"), which closed on March 19, 2021, we market a portfolio of prescription products addressing large markets with a focus on general pediatric conditions, attention deficit/hyperactivity disorder ("ADHD") and insomnia. We also market a portfolio of consumer health products also addressing large categories through our consumer health subsidiary, acquired in February 2020. Our goal is to become a leading specialty pharmaceutical company focused on large prescription and consumer health categories while building a late-stage development pipeline addressing significant medical needs.
Register and access this filing in:     
  FORM S-8
    2015 Stock Option and Incentive Plan
    CALCULATION OF REGISTRATION FEE
    PART I
      Item 1. Plan Information
      Item 2. Registrant Information and Employee Plan Annual ...
    PART II
      Item 3. Incorporation of Documents by Reference
    Item 4. Description of Securities
    Item 5. Interests of Named Experts and Counsel
      Item 6. Indemnification of Directors and Officers
      Item 7. Exemption From Registration Claimed
      Item 8. Exhibits
      ITEM 9. UNDERTAKINGS
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm